Skip to content

Evaluation of a physical therapy management program aimed at functional restoration for people with chronic complex regional pain syndrome type 1 of the lower extremity.

Evaluation of a physical therapy management program aimed at functional restoration for people with chronic complex regional pain syndrome type 1 of the lower extremity. - functional physical therapy treatment for people with CRPS1.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30110
Enrollment
20
Registered
2006-10-12
Start date
2006-08-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reflex Sympathetic Dystrophy Sudek Atrophy

Interventions

The intervention under study is one of the treatment modalities currently applied to patients with CRPS1 in Heliomare. Aim of the intervention is to restore motility and mobility of the affected joi

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Eligible are patients with a chronic Complex Regional Painsyndrome type 1 according to the criteria of the IASP; pain for at least six months; age between 18 and 65; no other treatment for the last 4 weeks.

Exclusion criteria

Exclusion criteria: Serious psychopathology based on the Symptom Checklist-90. structural limitations of the joint mobility that affect walking without aids. Patients willing to be treated according to the Dutch guidelines for the treatment of CRPS1. Patients with limited skills in the dutch language.

Design outcomes

Secondary

MeasureTime frame
Secundary outcome measures is health related quality of life as measured with the RAND-36 questionnaire.

Primary

MeasureTime frame
Primary outcome measures are functional limitations and pain. Functional limitations are measured with the performance based 10 meter walking test and the Timed up-and-go test and with the self report Patient Specific Complaints questionnaire.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)